UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

A phase III double blind, randomised, placebo controlled study of the efficacy, safety and tolerability of idebenone in the treatment of Friedreich's ataxia patients

Giunti, P; Gray, J; Wood, NW; (2007) A phase III double blind, randomised, placebo controlled study of the efficacy, safety and tolerability of idebenone in the treatment of Friedreich's ataxia patients. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1026 - 1026). B M J PUBLISHING GROUP

Full text not available from this repository.
Type: Proceedings paper
Title: A phase III double blind, randomised, placebo controlled study of the efficacy, safety and tolerability of idebenone in the treatment of Friedreich's ataxia patients
Event: ABN Spring Scientific Meeting 2007
Location: Homerton Coll, Cambridge, ENGLAND
Dates: 2007-04-11 - 2007-04-13
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Movement Neurosciences
URI: http://discovery.ucl.ac.uk/id/eprint/815254
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item